Prostate cancer is recognized as the most common among American men after skin cancer. This year, according to experts, at least 233 thousand new cases are expected to be diagnosed in the United States. Despite such a fairly high rate, deaths from this type of cancer are quite low.
Approximately 98.9% of men with this disease have a five-year survival rate. At the same time, many doctors believe that the improvement in the death rate since the early 90s of the last century is due to the use of a test to detect biomarkers of prostate cancer.
The U.S. State Commission on Drug Supervision first approved screening for the detection of a specific prostate antigen for asymptomatic men with suspected prostate cancer in the early 90s. In the decade preceding such approval, the five-year survival rate was 70-75%, by 1998 it had increased to 98.2%.
Despite the fact that some health experts consider this screening to be the best available method of checking men for possible prostate cancer, the mandatory use of this test has been the subject of debate for a long time.
Screening for the detection of a specific prostate antigen can lead to a fairly large number of false positive results. Moreover, the frequent use of this screening method can lead to overdiagnosis of the disease and the fact that many men will undergo a course of generally unnecessary treatment.
A specific prostate antigen is a substance consisting of prostate cells. During such screening, the level of this antigen in the patient's blood is measured in nanograms per milliliter in the laboratory. A high level of antigen (more than 4 ng/ml) may indicate the presence of prostate cancer, as a rule, men with this indicator should have a biopsy to determine the presence of cancer.
However, high levels of this antigen may also be due to less dangerous conditions, such as parostatitis, inflammation or infection of the prostate gland, or even enlargement of the prostate gland, which leads to difficulty urinating and some bladder problems. Also, the test for the detection of a specific prostate antigen is unable to determine the differences between aggressive malignant and benign tumors.
Previous studies have also shown that 17-50% of men diagnosed with prostate cancer using an antigen test have a tumor that does not cause symptoms throughout their lives. 1xBet Best Betting Offers in India All you have to do is provide the 1xbet promo code india when registering your new 1xBet account and you can receive a 130% first deposit match bonus as much as ₹42900! Registration at 1xBet India is easy with a few different sign-up methods. Betting sites introduce various bonuses for new and regular punters. These could be the welcome bonus for new players, free bet offers, a reload or a cashback offer on specific days of the week. Players can also win exclusive bonuses on their birthdays or referral rewards. Also, many sites have a VIP program to reward their regular customers.
Approximately 98.9% of men with this disease have a five-year survival rate. At the same time, many doctors believe that the improvement in the death rate since the early 90s of the last century is due to the use of a test to detect biomarkers of prostate cancer.
The U.S. State Commission on Drug Supervision first approved screening for the detection of a specific prostate antigen for asymptomatic men with suspected prostate cancer in the early 90s. In the decade preceding such approval, the five-year survival rate was 70-75%, by 1998 it had increased to 98.2%.
Despite the fact that some health experts consider this screening to be the best available method of checking men for possible prostate cancer, the mandatory use of this test has been the subject of debate for a long time.
Screening for the detection of a specific prostate antigen can lead to a fairly large number of false positive results. Moreover, the frequent use of this screening method can lead to overdiagnosis of the disease and the fact that many men will undergo a course of generally unnecessary treatment.
A specific prostate antigen is a substance consisting of prostate cells. During such screening, the level of this antigen in the patient's blood is measured in nanograms per milliliter in the laboratory. A high level of antigen (more than 4 ng/ml) may indicate the presence of prostate cancer, as a rule, men with this indicator should have a biopsy to determine the presence of cancer.
However, high levels of this antigen may also be due to less dangerous conditions, such as parostatitis, inflammation or infection of the prostate gland, or even enlargement of the prostate gland, which leads to difficulty urinating and some bladder problems. Also, the test for the detection of a specific prostate antigen is unable to determine the differences between aggressive malignant and benign tumors.
Previous studies have also shown that 17-50% of men diagnosed with prostate cancer using an antigen test have a tumor that does not cause symptoms throughout their lives. 1xBet Best Betting Offers in India All you have to do is provide the 1xbet promo code india when registering your new 1xBet account and you can receive a 130% first deposit match bonus as much as ₹42900! Registration at 1xBet India is easy with a few different sign-up methods. Betting sites introduce various bonuses for new and regular punters. These could be the welcome bonus for new players, free bet offers, a reload or a cashback offer on specific days of the week. Players can also win exclusive bonuses on their birthdays or referral rewards. Also, many sites have a VIP program to reward their regular customers.